NFKBIA and pancreatic neoplasm: In conclusion, our results suggest that miR-196a is overexpressed in pancreatic cancer cell lines, and down-regulation of miR-196a by anti-miR-196a suppresses proliferation and migration of pancreatic cancer, partially by targeting NFKBIA.